Addressing the management of patients with double exposed and refractory CLL

Understanding the mechanism of BTK inhibitors

---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

Strategic Sequencing in Relapsed Refractory Multiple Myeloma

---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

Prise en charge des patients atteints de LLC doublement exposée et réfractaire.

---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

Addressing the management of patients with double exposed and refractory CLL

Sponsored by Eli Lilly ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

CAR T-cell Therapy in 2025: Evidence, Safety, and Patient Selection

Sponsored by Bristol Myers Squibb. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.